Covance Softsol Ltd — Board Meeting, 14-08-2025: Board Meeting

Covance Softsol Limited's Board approved financial results for the quarter ended June 30, 2025: standalone profit after tax ₹8.28 Cr (EPS ₹5.61) and consolidated profit after tax ₹7.78 Cr (EPS ₹5.27), with consolidated total comprehensive income at ₹24.15 Cr. The Board also greenlit a rights issue to raise up to ₹7.50 Cr via fully paid-up equity shares, forming a committee for specific terms. Separately, Dr. Aravind Kumar Madala, an experienced general physician and son of Director Mr. Bhaskar Rao Madala, was appointed as an Additional Director, effective September 1, pending shareholder approval.